Applicant, as named in the Orange Book

Hoffmann La Roche

Next listed expiry: Zelboraf on 6 Jun 2032. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Zelboraf vemurafenib	vemurafenib	202429	6 Jun 2032	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.